Holen Sie sich die Stockscreener-App
29.04
0.92%
-0.27
Vorhandelsmarkt:
28.73
-0.31
-1.07%
Schlusskurs vom Vortag:
$29.31
Offen:
$29.35
24-Stunden-Volumen:
1.24M
Relative Volume:
0.85
Marktkapitalisierung:
$12.15B
Einnahmen:
$6.18B
Nettoeinkommen (Verlust:
$626.40M
KGV:
20.24
EPS:
1.435
Netto-Cashflow:
$848.81M
1W Leistung:
-3.55%
1M Leistung:
-4.57%
6M Leistung:
-19.62%
1J Leistung:
-22.37%
1-Tages-Spanne:
$29.02
$29.62
1-Wochen-Bereich:
$29.02
$30.40
52-Wochen-Spanne:
$28.55
$38.79
Smith Nephew Plc Adr Stock (SNN) Company Profile
Firmenname
Smith Nephew Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare SNN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
29.04 | 12.27B | 6.18B | 626.40M | 848.81M | 1.435 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-14 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-03-12 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-06 | Herabstufung | Berenberg | Buy → Hold |
| 2024-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-24 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-11-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2023-11-03 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-10-31 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-10-13 | Eingeleitet | Stifel | Hold |
| 2023-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2023-04-27 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-04-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | Eingeleitet | Citigroup | Buy |
| 2022-11-28 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-07-28 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-04 | Hochstufung | Redburn | Sell → Neutral |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | Eingeleitet | Barclays | Overweight |
| 2020-07-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-11-21 | Eingeleitet | Citigroup | Buy |
| 2019-11-12 | Eingeleitet | Bernstein | Outperform |
| 2019-07-23 | Hochstufung | Berenberg | Hold → Buy |
| 2019-02-08 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-12-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | Bestätigt | Canaccord Genuity | Buy |
| 2018-01-25 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-27 | Herabstufung | Goldman | Buy → Neutral |
| 2017-01-19 | Eingeleitet | HSBC Securities | Hold |
| 2016-12-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | Herabstufung | Berenberg | Buy → Hold |
| 2016-02-26 | Eingeleitet | Cantor Fitzgerald | Hold |
Alle ansehen
Smith Nephew Plc Adr Aktie (SNN) Neueste Nachrichten
Six medical stocks with sustainable dividends - The Globe and Mail
Smith & Nephew slides today as its finance chief heads for the exit? - Kalkine Media
Smith & Nephew tumbles after its finance chief resigns — how much does leadership matter? - Kalkine Media
What Is The Market Learning From Medical Products And Execution Across Global Healthcare Systems? - Kalkine Media
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics - Sahm
Smith & Nephew stock steadies as CEO share sale and analyst targets frame the outlook - Ad-hoc-news.de
Are Smith & Nephew (LSE:SN) And ConvaTec (LSE:CTEC) Rewriting London's Medtech Story Today? - Kalkine Media
Which Pressures Are Holding Back Smith & Nephew (LSE:SN.) And ConvaTec (LSE:CTEC) Right Now? - Kalkine Media
Smith & Nephew (SN.) Finalizes $250 Million Share Buyback After Acquiring Over 1 Million Shares in August 2026 - Kalkine Media
Cevian Capital Boosts Smith & Nephew (SN.) Stake to 14.21% After August 2026 Acquisition - Kalkine Media
Eli Lilly Upgraded, Best Buy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith & Nephew plc (SNN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Smith & Nephew Is Under Pressure from External Factors and Portfolio Gaps - Morningstar
Smith & Nephew (LSE:SN) Tests Whether Better Surgical Workflow Can Restore Orthopaedics Momentum - Kalkine Media
Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week - sahmcapital.com
Why Is Smith & Nephew (LSE:SN) Facing Fresh Market Attention? - Kalkine Media
Are Smith & Nephew (LSE:SN) And Convatec (LSE:CTEC) Defining The UK Healthcare Stocks Story? - Kalkine Media
Smith & Nephew (LSE:SN.) Moves to the Centre of the Healthcare Debate - Kalkine Media
Smith & Nephew Advances $250 Million Share Buyback, Repurchasing Over 1 Million Shares in Latest Week - Kalkine Media
What Smith & Nephew (LSE:SN) Says About The Current Blue-Chip Stocks Story - Kalkine Media
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care - Sahm
Smith & Nephew (NYSE: SNN) leaders buy ADS through employee stock plan - Stock Titan
Smith & Nephew Executives Acquire American Depositary Shares via Employee Stock Purchase Plan on July 10, 2026 - Kalkine Media
REGSmith & Nephew PlcDirector/PDMR Shareholding - TradingView
Could Orthopaedics Momentum Reshape The Story Around Smith & Nephew (LSE:SN.)? - Kalkine Media
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons - Sahm
Smith+Nephew introduces groundbreaking LYNX COBLATION Laryngeal Wand for ENT surgeons - Finviz
How Are Smith & Nephew (LSE:SN.) And ConvaTec (LSE:CTEC) Steering UK MedTech Sentiment? - Kalkine Media
SNN stock holds steady as Smith & Nephew keeps its investor focus - AD HOC NEWS
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR - GlobeNewswire Inc.
Why Is Smith & Nephew (LSE:SN.) Stock Being Watched After an Activist Investor Move? - Kalkine Media
Smith & Nephew plc ADR highlights its medical technology portfolio as investors weigh long-term grow - ad-hoc-news.de
Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis - ChartMill
Why is Smith & Nephew (LSE:SN.) stock falling today? - Kalkine Media
REGENETEN bioinductive implant from Smith & Nephew plcshoulder tendon repair with a quiet patch - Ad-hoc-news.de
ALLEVYN COMPLETE CARE Foam Dressing from Smith & Nephew plcnext-generation comfort for demanding - AD HOC NEWS
NPWA Forecast — Price Target — Prediction for 2027 - TradingView
Smith & Nephew consensus in focus, analysts keep a cautious hold on the shares - AD HOC NEWS
939163 Forecast — Price Target — Prediction for 2027 - TradingView
Thailand Advanced Wound Dressing Market Size & Outlook, 2033 - Grand View Research
Smith & Nephew strategy under new CEO, shares trade stable in London - AD HOC NEWS
Europe Antimicrobial Wound Care Dressings Market Size & Outlook, 2033 - Grand View Research
Smith & Nephew StockThursday technical picture and trading range - ad-hoc-news.de
Why Smith & Nephew’s PICO Single Use Negative Pressure System is changing tricky wound care - AD HOC NEWS
Why Smith & Nephew’s LEGION Revision Knee still matters in tough cases - AD HOC NEWS
Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty - Sahm
Smith & Nephew plc (ADR) stock (US83175M2052): U.K. medtech group draws interest after recent debt m - AD HOC NEWS
Smith & Nephew (NYSE: SNN) execs add ADS via dividend reinvestment - Stock Titan
Dell Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact - Sahm
SNNSmith & Nephew plc ADR Stock Price and Quote - Finviz
Finanzdaten der Smith Nephew Plc Adr-Aktie (SNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):